Budapest, Hungary

Katalin Szilagyi

This inventor holds 1 USPTO granted patent. Top assignee: Gyogyszerkutato Intezet Kft.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katalin Szilagyi. Retrieved from https://idiyas.com/inventor/katalin-szilagyi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katalin Szilagyi: Innovator in Pharmaceutical Chemistry

Introduction

Katalin Szilagyi is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on novel compounds.

Latest Patents

Katalin Szilagyi holds a patent for "Piperazine and homopiperazine derivatives, pharmaceutical compositions." This invention relates to novel compounds of the general formula (I) and the pharmaceutically acceptable acid addition salts thereof. The compounds of the general formula (I) inhibit lipid peroxidation, making them useful for the treatment or prevention of diseases and conditions where the inhibition of lipid peroxidation is desirable. She has 1 patent to her name.

Career Highlights

Katalin Szilagyi is associated with Gyogyszerkutato Intezet Kft., where she continues to advance her research and development efforts in pharmaceutical sciences. Her work has the potential to impact various therapeutic areas significantly.

Collaborations

Katalin has collaborated with notable colleagues, including Zoltan Zubovics and Katalin Goldschmidt, who contribute to her research endeavors.

Conclusion

Katalin Szilagyi's innovative work in pharmaceutical chemistry exemplifies the importance of research in developing new therapeutic compounds. Her contributions are paving the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…